Centre d'Information et de documentation du CRA Rhône-Alpes
CRA
Informations pratiques
-
Adresse
Centre d'information et de documentation
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexHoraires
Lundi au Vendredi
9h00-12h00 13h30-16h00Contact
Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Résultat de la recherche
3 recherche sur le mot-clé 'mental illness'
Affiner la recherche Générer le flux rss de la recherche
Partager le résultat de cette recherche Faire une suggestion
Chronic illness in childhood and early adolescence: A longitudinal exploration of co-occurring mental illness / Ann Marie BRADY in Development and Psychopathology, 33-3 (August 2021)
[article]
Titre : Chronic illness in childhood and early adolescence: A longitudinal exploration of co-occurring mental illness Type de document : Texte imprimé et/ou numérique Auteurs : Ann Marie BRADY, Auteur ; Jessica DEIGHTON, Auteur ; Stephen STANSFELD, Auteur Article en page(s) : p.885-898 Langues : Anglais (eng) Mots-clés : chronic illness early adolescence mediation mental illness peer victimization school Index. décimale : PER Périodiques Résumé : Chronic health conditions are hypothesized to disrupt the typical trajectory of child and adolescent development, and subsequently lead to increased levels of mental illness. However, due to methodological limitations in existing studies, this theory remains to be fully substantiated by empirical research. This study aimed to more thoroughly test hypotheses in the field. This study used data from the Avon Longitudinal Study of Parents and Children to examine the co-occurrence of mental illness among children with chronic illness in late childhood into early adolescence and explore mediating factors in these outcomes. Children with chronic health problems presented with a disproportionate rate of psychiatric illness at 10 years, and these chronic health problems continued to be associated with poor mental health outcomes at 13 years and 15 years. These outcomes were mediated by high levels of peer victimization and health-related school absenteeism. This study suggests that chronic illness may impact on functioning and social development in early adolescence, and consequently lead to increased rates of mental illness. Examining rates of school absenteeism and peer victimization may be key to identifying children at risk over time. En ligne : http://dx.doi.org/10.1017/S0954579420000206 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=457
in Development and Psychopathology > 33-3 (August 2021) . - p.885-898[article] Chronic illness in childhood and early adolescence: A longitudinal exploration of co-occurring mental illness [Texte imprimé et/ou numérique] / Ann Marie BRADY, Auteur ; Jessica DEIGHTON, Auteur ; Stephen STANSFELD, Auteur . - p.885-898.
Langues : Anglais (eng)
in Development and Psychopathology > 33-3 (August 2021) . - p.885-898
Mots-clés : chronic illness early adolescence mediation mental illness peer victimization school Index. décimale : PER Périodiques Résumé : Chronic health conditions are hypothesized to disrupt the typical trajectory of child and adolescent development, and subsequently lead to increased levels of mental illness. However, due to methodological limitations in existing studies, this theory remains to be fully substantiated by empirical research. This study aimed to more thoroughly test hypotheses in the field. This study used data from the Avon Longitudinal Study of Parents and Children to examine the co-occurrence of mental illness among children with chronic illness in late childhood into early adolescence and explore mediating factors in these outcomes. Children with chronic health problems presented with a disproportionate rate of psychiatric illness at 10 years, and these chronic health problems continued to be associated with poor mental health outcomes at 13 years and 15 years. These outcomes were mediated by high levels of peer victimization and health-related school absenteeism. This study suggests that chronic illness may impact on functioning and social development in early adolescence, and consequently lead to increased rates of mental illness. Examining rates of school absenteeism and peer victimization may be key to identifying children at risk over time. En ligne : http://dx.doi.org/10.1017/S0954579420000206 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=457 Honest, Open, Proud for adolescents with mental illness: pilot randomized controlled trial / N. MULFINGER in Journal of Child Psychology and Psychiatry, 59-6 (June 2018)
[article]
Titre : Honest, Open, Proud for adolescents with mental illness: pilot randomized controlled trial Type de document : Texte imprimé et/ou numérique Auteurs : N. MULFINGER, Auteur ; S. MULLER, Auteur ; I. BOGE, Auteur ; V. SAKAR, Auteur ; P. W. CORRIGAN, Auteur ; Sara EVANS-LACKO, Auteur ; L. NEHF, Auteur ; J. DJAMALI, Auteur ; A. SAMARELLI, Auteur ; M. KEMPTER, Auteur ; C. RUCKES, Auteur ; G. LIBAL, Auteur ; N. OEXLE, Auteur ; M. NOTERDAEME, Auteur ; N. RUSCH, Auteur Article en page(s) : p.684-691 Langues : Anglais (eng) Mots-clés : Coming Out Proud Honest, Open, Proud Randomized controlled trial adolescents disclosure mental illness secrecy Index. décimale : PER Périodiques Résumé : BACKGROUND: Due to public stigma or self-stigma and shame, many adolescents with mental illness (MI) struggle with the decision whether to disclose their MI to others. Both disclosure and nondisclosure are associated with risks and benefits. Honest, Open, Proud (HOP) is a peer-led group program that supports participants with disclosure decisions in order to reduce stigma's impact. Previously, HOP had only been evaluated among adults with MI. METHODS: This two-arm pilot randomized controlled trial included 98 adolescents with MI. Participants were randomly assigned to HOP and treatment as usual (TAU) or to TAU alone. Outcomes were assessed pre (T0/baseline), post (T1/after the HOP program), and at 3-week follow-up (T2/6 weeks after T0). Primary endpoints were stigma stress at T1 and quality of life at T2. Secondary outcomes included self-stigma, disclosure-related distress, empowerment, help-seeking intentions, recovery, and depressive symptoms. The trial is registered on ClinicalTrials (NCT02751229; http://www.clinicaltrials.gov). RESULTS: Compared to TAU, adolescents in the HOP program showed significantly reduced stigma stress at T1 (d = .92, p < .001) and increased quality of life at T2 (d = .60, p = .004). In a longitudinal mediation model, the latter effect was fully mediated by stigma stress reduction at T1. HOP further showed significant positive effects on self-stigma, disclosure-related distress, secrecy, help-seeking intentions, attitudes to disclosure, recovery, and depressive symptoms. Effects at T1 remained stable or improved further at follow-up. In a limited economic evaluation HOP was cost-efficient in relation to gains in quality of life. CONCLUSIONS: As HOP is a compact three-session program and showed positive effects on stigma and disclosure variables as well as on symptoms and quality of life, it could help to reduce stigma's negative impact among adolescents with MI. En ligne : http://dx.doi.org/10.1111/jcpp.12853 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=363
in Journal of Child Psychology and Psychiatry > 59-6 (June 2018) . - p.684-691[article] Honest, Open, Proud for adolescents with mental illness: pilot randomized controlled trial [Texte imprimé et/ou numérique] / N. MULFINGER, Auteur ; S. MULLER, Auteur ; I. BOGE, Auteur ; V. SAKAR, Auteur ; P. W. CORRIGAN, Auteur ; Sara EVANS-LACKO, Auteur ; L. NEHF, Auteur ; J. DJAMALI, Auteur ; A. SAMARELLI, Auteur ; M. KEMPTER, Auteur ; C. RUCKES, Auteur ; G. LIBAL, Auteur ; N. OEXLE, Auteur ; M. NOTERDAEME, Auteur ; N. RUSCH, Auteur . - p.684-691.
Langues : Anglais (eng)
in Journal of Child Psychology and Psychiatry > 59-6 (June 2018) . - p.684-691
Mots-clés : Coming Out Proud Honest, Open, Proud Randomized controlled trial adolescents disclosure mental illness secrecy Index. décimale : PER Périodiques Résumé : BACKGROUND: Due to public stigma or self-stigma and shame, many adolescents with mental illness (MI) struggle with the decision whether to disclose their MI to others. Both disclosure and nondisclosure are associated with risks and benefits. Honest, Open, Proud (HOP) is a peer-led group program that supports participants with disclosure decisions in order to reduce stigma's impact. Previously, HOP had only been evaluated among adults with MI. METHODS: This two-arm pilot randomized controlled trial included 98 adolescents with MI. Participants were randomly assigned to HOP and treatment as usual (TAU) or to TAU alone. Outcomes were assessed pre (T0/baseline), post (T1/after the HOP program), and at 3-week follow-up (T2/6 weeks after T0). Primary endpoints were stigma stress at T1 and quality of life at T2. Secondary outcomes included self-stigma, disclosure-related distress, empowerment, help-seeking intentions, recovery, and depressive symptoms. The trial is registered on ClinicalTrials (NCT02751229; http://www.clinicaltrials.gov). RESULTS: Compared to TAU, adolescents in the HOP program showed significantly reduced stigma stress at T1 (d = .92, p < .001) and increased quality of life at T2 (d = .60, p = .004). In a longitudinal mediation model, the latter effect was fully mediated by stigma stress reduction at T1. HOP further showed significant positive effects on self-stigma, disclosure-related distress, secrecy, help-seeking intentions, attitudes to disclosure, recovery, and depressive symptoms. Effects at T1 remained stable or improved further at follow-up. In a limited economic evaluation HOP was cost-efficient in relation to gains in quality of life. CONCLUSIONS: As HOP is a compact three-session program and showed positive effects on stigma and disclosure variables as well as on symptoms and quality of life, it could help to reduce stigma's negative impact among adolescents with MI. En ligne : http://dx.doi.org/10.1111/jcpp.12853 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=363 Editorial: Biomarkers in precision medicine for mental illnesses / Bradley S. PETERSON in Journal of Child Psychology and Psychiatry, 61-12 (December 2020)
[article]
Titre : Editorial: Biomarkers in precision medicine for mental illnesses Type de document : Texte imprimé et/ou numérique Auteurs : Bradley S. PETERSON, Auteur Article en page(s) : p.1279-1281 Langues : Anglais (eng) Mots-clés : Precision medicine biomarkers endophenotype mental illness personalized medicine prediction public health treatment validation Index. décimale : PER Périodiques Résumé : Precision medicine and biomarker development have become the prevailing paradigm for mental health research. Despite its conceptual elegance and dominance as a research framework, precision medicine has a very limited track record of demonstrable success thus far for mental illnesses, due in varying degrees to the complexity of both the brain and the pathophysiology of mental illnesses, which limits our ability to develop, replicate, and validate biomarkers for use in enhancing clinical care for mental illnesses, especially in high-risk and complex clinical populations. Research and funding priorities should integrate biomarker development and precision medicine interventions that target the robust behavioral, environmental, and social determinants that we know are important for population-based mental health. En ligne : http://dx.doi.org/10.1111/jcpp.13357 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=434
in Journal of Child Psychology and Psychiatry > 61-12 (December 2020) . - p.1279-1281[article] Editorial: Biomarkers in precision medicine for mental illnesses [Texte imprimé et/ou numérique] / Bradley S. PETERSON, Auteur . - p.1279-1281.
Langues : Anglais (eng)
in Journal of Child Psychology and Psychiatry > 61-12 (December 2020) . - p.1279-1281
Mots-clés : Precision medicine biomarkers endophenotype mental illness personalized medicine prediction public health treatment validation Index. décimale : PER Périodiques Résumé : Precision medicine and biomarker development have become the prevailing paradigm for mental health research. Despite its conceptual elegance and dominance as a research framework, precision medicine has a very limited track record of demonstrable success thus far for mental illnesses, due in varying degrees to the complexity of both the brain and the pathophysiology of mental illnesses, which limits our ability to develop, replicate, and validate biomarkers for use in enhancing clinical care for mental illnesses, especially in high-risk and complex clinical populations. Research and funding priorities should integrate biomarker development and precision medicine interventions that target the robust behavioral, environmental, and social determinants that we know are important for population-based mental health. En ligne : http://dx.doi.org/10.1111/jcpp.13357 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=434